Pfizer, inc. will pay $1 million to Oregon and run advertising nationally to correct prior ad campaigns that allegedly misrepresented risks and benefits of products.
The new settlement, filed in Marion County Circuit Court, concerns ads for EpiPen, the company's injectable form of epinephrine, and Zmax, an antiobiotic.
In May, the federal Food and Drug administration issued a warning letter saying an ad called "Max's Birthday Party" had downplayed the "serious risks" of EpiPen. The ad was issued by a firm called Mylan Specialty, L.P. on behalf of Pfizer. The FDA called for corrective advertising.
In June the FDA issued a similar warning over an ad for Zmax, known also as zithromax.
Pfizer agreed to the Oregon settlement after the state Department of Justice accused it of violating previous agreements with the state, in which the company agreed to not make misleading claims.
In the last 12 months, the state has recovered more than $16.5 million in consumer protection settlements from drug and medical product companies.
Distributed by MCT Information Services
Most Popular Stories
- SEO Traffic Lab Celebrate Wins at Digital Marketing Event 'Internet World 2013' in London
- Social Media Initiatives Should Follow Customers' Lead
- Apple CEO: Offshore Units Not a 'Tax Gimmick'
- U.S. Senate Accuses Apple of Large-scale Tax Avoidance
- UTEP Water Recycling Project Wins Venture Titles
- Marketo Makes a Mint in IPO: Stock Shoots Up More than 50 Percent
- Bieber Booed at Billboard Awards
- Crude Oil Up, Gasoline Down
- Austin Startup Compare Metrics Raises $3.5 Million for Expansion
- Why So Many Top 'Car Guys' Are Actually Women